Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-04

FDA Approved: NALOXONE HYDROCHLORIDE — Supplemental Application (Par Health USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for naloxone hydrochloride submitted by Par Health USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naloxone Hydrochloride (Naloxone hydrochloride)

Snippet

SUPPL AP for NALOXONE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE)